Abstract
Double immunostaining for Fos and γ-aminobutyric acid (GABA) was used in a previously established animal model of striatal dysfunction to examine whether GABA-immunoreactive neurons in the globus pallidus (GP) and entopeduncular nucleus (EP) are activated to express Fos immunoreactivity by intraperitoneal injection of amphetamine. Striatal efferent activity was suppressed by intrastriatal infusions of antisense oligodeoxynucleotide targeted to the messenger RNA of the immediate early gene, c-fos. This suppression produced robust rotational behavior and expression of Fos in the ipsilateral GP and EP following amphetamine challenge. The expression of Fos in the ipsilateral GP and EP following amphetamine challenge is not observed in naïve or control antisense-treated animals. Quantitative analysis revealed that a majority of the amphetamine-activated (Fos-immunoreactive) neurons in the GP and EP express GABA. The present results suggest that inhibitory GABAergic projection neurons within these two nuclei are regulated by inhibitory striatal output and suggests that decreased inhibitory striatal output may contribute to the motor dysfunction observed in patients with Huntington's disease.
Original language | English |
---|---|
Pages (from-to) | 275-281 |
Number of pages | 7 |
Journal | Experimental Neurology |
Volume | 175 |
Issue number | 1 |
DOIs | |
Publication status | Published - 2002 |
Bibliographical note
Funding Information:This research was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science. We thank Professor K. Semba (Department of Anatomy and Neurobiology, Dalhousie University), for her advice on immunohistochemistry, and Ms. K. Murphy, for excellent technical support.
ASJC Scopus Subject Areas
- Neurology
- Developmental Neuroscience